Teva Pharmaceuticals (NYSE:TEVA) will pay $519 million to settle allegations that the company bribed overseas officials in Mexico, Russia and Ukraine to promote its products, according to the U.S. Justice Dept. The department reported that the millions of dollars in bribes occurred for more than a decade.
The pharmaceutical giant agreed to $238 million to settle Foreign Corrupt Practices Act allegations, as well as $236 million in profits plus interest to resolve the Securities and Exchange Commission’s civil investigation.
Get the full story at our sister site, Drug Delivery Business News.
The post Teva coughs up $519m to settle overseas bribery charges appeared first on MassDevice.
from MassDevice http://ift.tt/2hhin5c
Cap comentari:
Publica un comentari a l'entrada